Proton therapy technology is the least of your worries.

Proton therapy lived in large research institutes for almost half a century. The method used to convert a current of protons into a beam that could be used to treat tumors was limited by the technology that was available from the 1950’s onwards. In 1986 pencil beam scanning (PBS) was introduced at the Paul Scherrer Institut. PBS allows for the maximal reduction in integral dose. With the PBS delivery technique of  Intensity Modulated Proton Therapy (IMPT) it also provides greatest flexibility in shaping the dose distribution.

It took two more decades — and further advancements in especially imaging — before PBS was fully recognised as the way forward. Today all vendors provide PBS as their main or even only method of treatment delivery. As all protons are created equal there are only marginal differences in the quality of the dose distributions delivered by the various vendor solutions.

Of course there is still enough to choose between, and identifying the right vendor for an initiative is still important. But it is important to realise why proton therapy initiatives have stalled, and why too many proton therapy centers have struggled to the point of bankruptcy1. The reasons include the following:

  • Not having made transparent how offering proton therapy aligns with the mission of the organisation
  • Overestimating how many of their own radiotherapy patients would benefit from proton therapy
  • Assuming the mere offering of proton therapy treatments would result in substantial patient referral
  • Underestimating the time the organisation needed to climb the learning curve
  • Failing to engage with stakeholders in a structural and timely fashion

There are still other reasons too, but “because of failing equipment” is not among them.

 

***

If you found this to be of interest perhaps you may want to read the following original contributions: Solutions in proton therapy — for initiatives (a report), Procuring proton therapy equipment (a case) and A Business Case for a proton therapy initiative (a case).

Back to all explanations Message me about this explanation
This is how we make proton therapy a success

Proton Therapy’s biggest problem is lack of transparency.

Proton Therapy's biggest problem is lack of transparency. Initiatives don't share their overall aims, vendors focus on technology. Everybody is blind to the other side's needs and capabilities. But there is another way.

Read more

You can start to minimise risk in proton therapy today.

A decision is a conclusion reached after careful consideration. If you have to think it means something is not transparent. Each decision increases risk. Risk is minimised by unambiguous aims and access to expertise. You find it here.

Read more

Independent consultancy made the difference for us.

Proton therapy vendors have a lot of expertise and a need to sell equipment. They may not protest when unrealistic assumptions are made. Some consultants combine great expertise with ties to a vendor. Independent consultancy can make a difference.

Read more

Proton therapy technology is the least of your worries.

There is too much risk in the field of proton therapy, but the problem is not the technology. Focussing on technology often results in underestimating the real challenges. Challenges a vendor may help you with.

Read more
All explanations >
Patient selection and patient referral are pivotal.

Many proton therapy centers struggle because of an unrealistic projection of the number of patients that will be treated. In the past, and even in the present, the number of patients projected to be treated was simply the number that was required to make the business case look good. Today we know that the most successful centers treat, on average, no more than 300 patients per treatment room. But to achieve even this number takes great effort. There is the challenge of identifying the patients who will benefit from proton therapy, and there is the challenge of getting these people referred to the center.

Read more
Don’t buy equipment, identify the right vendor.

Initiatives who want to provide proton therapy treatments — often hospital organisations — are confronted with very complex and very capital intensive equipment they have never procured before. A proton therapy project is perceived as a major risk, and rightly so. Too many centers have failed or are failing. The risk lies not with the equipment, however. All vendors build reliable machinery delivering identical protons. Not all vendors, however, provide the same expertise and solutions. Initiatives should not focus on technology, but on identifying the vendor who is best able to meet their particular challenges.

Read more
You can start to minimise risk in proton therapy today.

A decision is a conclusion reached after careful consideration. If you have to think about something it means this something is not transparent. If you take a decision when something is not transparent risk increases. This risk is minimised by unambiguous aims and access to expertise. What is it that you need to achieve? Who is the expert that will help you achieve it? Trees with Character helps with both.

Read more
Proton therapy technology is the least of your worries.

Cyclotrons and synchrotrons alike are built to last for decades — as is shown by the early proton therapy centers who became operational in the previous millennium. To this day, however, the complexity of the equipment often is an initiative’s biggest concern and many resources are spent on trying to understand it. Meanwhile none of the proton therapy centers who failed failed because of the technology. There are other, much more relevant issues and challenges to be considered.

Read more
Independent consultancy made the difference for us.

Proton therapy vendors have a lot of expertise. They also need to sell their equipment and associated services and may not point out which of an initiative’s assumptions are unrealistic. Some consultants possess great expertise — as well as an agreement with a vendor. Independent consultancy can make a difference. Independent consultancy means that the only interest to consider is your interest. Trees with Character will help you to make the right choices.

Read more
Proton Therapy’s biggest problem is lack of transparency.

Initiatives don’t share their overall aims, vendors focus on technology. Everybody is blind to the other side’s needs and capabilities. Without transparency everything is a risk. Everybody is looking for safety and control. Many resources are spent on inspections, on meetings, on the contract. But there is another way.

Read more